RE: Scancell on Sky News!14 Feb 2021 15:45
C7 it refers to the funding we already have... from the funding RNS@
'Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces that it has secured funding from Innovate UK, the UK's Innovation Agency, through the 'UK Research and Innovation (UKRI) Ideas to Address COVID-19' funding strand. The funding will be used to initiate a Phase 1 clinical trial ("COVIDITY") during 2021.'
So the initiating has begun.